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Abstract
Background: Niemann-Pick disease type A (NPDA), a disease caused by mutations in acid sphingomyelinase (ASM),
involves severe neurodegeneration and early death. Intracellular lipid accumulation and plasma membrane
alterations are implicated in the pathology. ASM is also linked to the mechanism of plasma membrane repair,
so we investigated the impact of ASM deficiency in skeletal muscle, a tissue that undergoes frequent cycles of
injury and repair in vivo.
Methods: Utilizing the NPDA/B mouse model ASM−/− and wild type (WT) littermates, we performed excitation-
contraction coupling/Ca2+ mobilization and sarcolemma injury/repair assays with isolated flexor digitorum brevis
fibers, proteomic analyses with quadriceps femoris, flexor digitorum brevis, and tibialis posterior muscle and in vivo
tests of the contractile force (maximal isometric torque) of the quadriceps femoris muscle before and after eccentric
contraction-induced muscle injury.
Results: ASM−/− flexor digitorum brevis fibers showed impaired excitation-contraction coupling compared to WT,
a defect expressed as reduced tetanic [Ca2+]i in response to electrical stimulation and early failure in sustaining [Ca
2+]i
during repeated tetanic contractions. When injured mechanically by needle passage, ASM−/− flexor digitorum brevis
fibers showed susceptibility to injury similar to WT, but a reduced ability to reseal the sarcolemma. Proteomic analyses
revealed changes in a small group of skeletal muscle proteins as a consequence of ASM deficiency, with downregulation
of calsequestrin occurring in the three different muscles analyzed. In vivo, the loss in maximal isometric torque of
WT quadriceps femoris was similar immediately after and 2 min after injury. The loss in ASM−/− mice
immediately after injury was similar to WT, but was markedly larger at 2 min after injury.
Conclusions: Skeletal muscle fibers from ASM−/− mice have an impairment in intracellular Ca2+ handling
that results in reduced Ca2+ mobilization and a more rapid decline in peak Ca2+ transients during repeated
contraction-relaxation cycles. Isolated fibers show reduced ability to repair damage to the sarcolemma, and
this is associated with an exaggerated deficit in force during recovery from an in vivo eccentric contraction-
induced muscle injury. Our findings uncover the possibility that skeletal muscle functional defects may play a
role in the pathology of NPDA/B disease.
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Background
Niemann-Pick disease types A and B (NPDA/B) are
diseases caused by recessive mutations in SMPD1, the
gene encoding the lysosomal enzyme acid sphingomyeli-
nase (ASM). NPDA, the most serious form of the disease,
is characterized by very low ASM activity (< 5% of normal
levels), extensive neurodegeneration, and early death at
around 2 years of age. NPDB, on the other hand, presents
a phenotypic heterogeneity that is attributed to partial
ASM deficiency (5–10% of normal levels) [1, 2]. The birth
rate of NPDA children in the Ashkenazi Jewish commu-
nity is estimated at approximately 1:40,000. In this
population, three mutations account for > 90% of infants
diagnosed with NPDA, and DNA-based screening of
Ashkenazi adults estimate the carrier frequency for these
mutations at 1:80–1:100 [1]. Thus, NPDA and NPDB
represent very serious health concerns in certain hu-
man populations.
ASM hydrolyses the head group of sphingomyelin,
generating phosphorylcholine and ceramide. NPDA and
NPDB have characteristics of lysosomal storage diseases,
because intra-lysosomal accumulation of lipids resulting
from ASM deficiency is thought to lead to cellular dys-
function and death, particularly in neurons. However,
during the last decade, it has become apparent that
ASM also has an extracellular role, remodeling lipid mi-
crodomains on the outer leaflet of the plasma membrane
(PM) after being secreted during conditions of cellular
stress [3–7]. These findings have led to the suggestion
that the clinical findings in NPDA/B might also be due
to PM abnormalities [7]. In particular, recent studies
uncovered a link between the extracellular release of
ASM from lysosomes and the mechanism by which cells
repair wounds to their PM [8, 9].
Injury and repair of the PM is a normal physiological
process that occurs in many cell types [10–13] and is
particularly frequent in tissues under mechanical stress
such as the skeletal muscle [14–16]. A major advance in
the understanding of PM repair came from the
realization that lysosomes, in addition to their role as
intracellular degradative organelles, respond to the influx
of Ca2+ through PM wounds by fusing with the PM [17,
18]. Ca2+-triggered exocytosis of lysosomes is required
for the repair of PM lesions in several cell types [9, 11,
12, 19], through a process that was initially thought to
involve a membranous “repair patch” [20]. However,
recent studies revealed that the extracellular release of
ASM from lysosomes after wounding has a direct role in
PM resealing by promoting lesion removal through
endocytosis [21, 22]. Thus, impaired PM repair after
injury may be an important but so far overlooked com-
ponent of the pathophysiology of NPDA/B. In this study,
we investigated this hypothesis by focusing on the skel-
etal muscle, a tissue that is frequently injured in vivo
[14, 16], using an ASM knockout mouse model that shows
clinical, biochemical, and pathological abnormalities that
mimic the characteristics of human NPDA/B [23, 24].
These ASM−/− mice develop ataxia and tremors at
approximately 8 weeks after birth, followed by a rapidly
progressing neurodegeneration that culminates in unre-
sponsiveness, lethargy, and death by 6–8months of age.
Prior to this study, however, no information was available
on the skeletal muscle function of these animals.
Methods
Animal handling and flexor digitorum brevis (FDB) muscle
fiber isolation
ASM+/− mice (generated by E. Schuchman and provided
by S. Muro, University of Maryland) were bred to gener-
ate ASM−/− and ASM+/+ (WT) littermates. All protocols
for animal handling were approved by the University of
Maryland’s Institutional Animal Care and Use Commit-
tee (IACUC). The University of Maryland at College
Park is an AAALAC-accredited institution. At about 8
weeks of age, gender-matched mice (male or female
animals were used in most assays with no differences
observed) were euthanized, and the FDB muscle was ex-
cised and digested with 0.2% type 2 collagenase/minimal
essential media (MEM)/10% fetal bovine serum (FBS)
solution at 37 °C in a 5% CO2 atmosphere for 4 h to
obtain FDB single muscle fibers [25, 26].
FDB mechanical wounding
After collagenase digestion, FDB fibers were gently dis-
sociated by several passages in a Pasteur pipette and
washed twice in DMEM without Ca2+ using spontaneous
sedimentation (1 g) for 15 min at room temperature
followed by removal of the supernatant. The fibers were
then resuspended in 1.2ml DMEM without Ca2+ + 10mM
EGTA, and aliquots of 200 μl were transferred to six tubes
and again allowed to sediment. The supernatant was re-
moved, the fibers were resuspended in 1ml DMEM with
Ca2+ (condition permissive for sarcolemma repair) or 1ml
DMEM without Ca2+ (condition not permissive for sarco-
lemma repair) and allowed to sediment for 15min on ice.
The sedimented fibers were then passed through a
30-gauge needle using a 1-ml syringe (pulling the plunger
up and down once), incubated at 37 °C for 5min, followed
by addition of propidium iodide (PI) (1:50 dilution of
5 mg/ml solution). After 5 min on ice, 1 ml of DMEM
without Ca2+ 10 mM EGTA was added and the fibers
were allowed to sediment for 15 min on ice. After
removing the supernatant, the fibers in each tube
were resuspended in 500 μl PBS 4% paraformaldehyde
(PFA) and left at room temperature for 15min, centri-
fuged at 21×g for 5min and resuspended in 0.25ml PBS
and imaged in DeltaVision deconvolution microscope
using a × 10 objective. PI staining levels in fibers were
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determined by fluorescence intensity measurements using
Volocity software, on > 200 fibers for each experimental
condition. Hyper-contracted fibers, which were PI-positive
under all conditions, were excluded from the analysis.
Electron microscopy
Isolated FDB fibers were injured by passage through a
30-gauge needle as described above. Fibers were then
immediately incubated at 37 °C for 1 min to induce the
sarcolemma repair reaction, before being placed in an
ice-cold bath to stop the process. Non-wounded control
fibers were also placed on ice. All fibers were then
allowed to sediment for 15 min on ice before being
washed in ice-cold PBS, sedimented again, and finally
resuspended in ice-cold 2% glutaraldehyde in 0.1M
cacodylate fixative and placed at room temperature for
1 h before being processed for transmission electron
microscopy (TEM) and imaged in a Zeiss EM10CA
electron microscope, as previously described [25].
Intracellular Ca2+ measurements
Fura-2 AM was used to assess changes in intracellular Ca2+
levels in single muscle fibers, as previously described [26].
Briefly, after single muscle fibers were isolated from FDB
muscle, the fibers were loaded with Fura-2 AM for 15min,
which allows the fluorescent dye sufficient time to diffuse
into the myoplasm. Fura-2 emits a signal when excited at
380 nm (unbound state) or at 340 nm (bound to Ca2+), and
the ratio at 340 nm/380 nm reflects the relative intracellular
Ca2+ concentration ([Ca2+]i). The loaded fibers were then
washed of excess dye and placed in a stimulation chamber
containing parallel electrodes. The stimulation chamber
was placed on top of a Nikon TiU microscope, and the
IonOptix Hyperswitch system was used to assess the
Fura-2 fluorescence ratio.
Single muscle fiber stimulation protocol
For the assessment of muscle fiber [Ca2+]i, fibers were
perfused with a stimulation solution comprised of 121
mM NaCl, 5 mM KCl, 0.5 mM MgCl2, 0.4 mM
NaH2PO4, 24 mM NaHCO3, 5.5 mM glucose, and 1.8
mM CaCl2 [27]. Fetal bovine serum (FBS) (0.2%) was
added to the stimulation solution, which was continu-
ously aerated with 95% O2/5% CO2 and maintained at
pH 7.3 [27]. Intracellular [Ca2+] was measured in single
muscle fibers across a range of pulse frequencies (10, 30,
50, 70, 100, 120, and 150Hz) to establish a Ca2+-frequency
relationship. The 10–150 Hz pulses were delivered as
350 ms pulse trains with a 1-min interval between fre-
quencies (i.e., seven stimulation frequencies assessed
over 7 min) to minimize the potential for fatigue. Fol-
lowing the Ca
2+
-frequency assessment, muscle fibers
were allowed to recover for 5 min before the repeated
tetanic contraction (RTC) protocol.
The RTC protocol consisted of intermittent 100 Hz
tetani (350 ms duration), with the duration of the rest
periods between tetanic contractions reduced every 2
min, as previously described [27]. The fibers underwent
one contraction every 4 s for 2 min, then one contraction
every 3 s for 2 min, then one contraction every 2 s for
2 min, and finally one contraction every second, until
the peak Fura-2 ratio was reduced to 50% of the initial
ratio [27]. This 50% decrease in peak Ca2+ transient was
previously shown to correspond to a 70% decrease in
force in isolated fibers exposed to RTC and defined as
the point of fatigue [28]. Following the RTC, the
Ca2+-frequency relationship was reassessed 30 and
60 min after the last 100 Hz tetanus to determine the
frequency-dependent recovery of [Ca2+]i and E-C
coupling from repetitive contraction-relaxation cycles.
A two-way analysis of variance (ANOVA) of Fura-2
ratios at each stimulation frequency was performed to
analyze the results, with statistical significance set at
an α level of 0.05.
SERCA1 and calsequestrin protein expression
Total protein was isolated from FDB by homogenization
in lysis buffer (20 mM HEPES buffer, pH 7.5, 100 mM
NaCl, 1.5 mM MgCl2, 0.1% Triton X-100, 20% glycerol)
containing 1 mM DTT and a protease inhibitor cocktail
(Sigma) on ice. Samples were centrifuged at 20,000 g at
4 °C, and the supernatant was collected and frozen at
− 80 °C until analyzed. Total protein concentration was
determined using a BCA assay (Thermo Fisher Scientific).
Samples were solubilized in SDS loading buffer and
denatured by heating at 100 °C for 5min. For immunoblot-
ting, 20–30 μg total protein was loaded on bis-acrylamide
gels, separated by SDS-PAGE electrophoresis, and trans-
ferred to PVDF membranes (EMD Millipore, Billerica, MA,
USA). Membranes were blocked with 5% nonfat milk at
room temperature for 1 h followed by overnight incubation
at 4 °C in anti-SERCA1 (Thermo Fisher Scientific) or
anti-calsequestrin polyclonal antibodies (Abcam ab3516).
Antibodies against α-tubulin or actin (Abcam) were
used as loading controls. Antibody-reactive proteins
were detected with Clarity western ECL substrate
(Bio-Rad, Hercules, CA, USA), imaged using an Image
Lab system (Bio-Rad), and quantified by densitometry.
Proteomics analysis
Independently isolated (three biological replicates) quad-
riceps femoris (QF), tibialis posterior (TP), and FDB
muscles from WT or ASM−/− mice were lysed in 0.1M
Tris-HCL, pH 7.4, 0.1M DTT and 4% SDS and incu-
bated at 95 °C for 5 min, followed by homogenization in
a Tissue-Tearer (Model 985370, Biospec Products). After
sonication (Branson), the lysates were centrifuged at
16,000×g for 10 min, and samples of the supernatant
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containing about 25 μg protein were reduced, alkylated,
and digested within S-Trap micro spin columns (Protifi)
following the manufacturer’s recommendations. In short,
homogenates containing 2% SDS were reduced with DTT
and cysteine-alkylated with iodoacetamide. The protein so-
lution was then acidified with phosphoric acid, diluted with
90% MeOH, and loaded into S-Trap micro columns. The
captured protein was washed with 90% MeOH to remove
SDS and trypsin was added at 1:25 w/w ratio followed
by incubation at 47 °C for 1 h. Tryptic peptides were
sequentially eluted with 50 mM triethylamine bicar-
bonate, 0.2% formic acid, and 50% acetonitrile con-
taining 0.2% formic acid. Eluents were combined, and
the solvent removed by centrifugal evaporation.
Nano LC-MS/MS analysis was carried out with a
Thermo Scientific Fusion Lumos tribrid mass spectrom-
eter interfaced to a UltiMate3000 RSLCnano HPLC sys-
tem. One microgram of the tryptic digest was loaded
and desalted in an Agilent Zorbax 300 SB-C18 trapping
column (0.3 × 5mm) at 5 μl/min for 5 min. Peptides
were then eluted into a 75 μm× 250mm Thermo Scien-
tific Accalaim PepMap 100 column (3 μm, 100 Å) and
chromatographically separated using a binary solvent
system consisting of A: 0.1% formic acid and 2.5% aceto-
nitrile and B: 0.1% formic acid and 75% acetonitrile, at a
flow rate of 300 nl/min. A gradient was run from 1% B
to 42% B over 150min, followed by a 5-min wash step
with 99% B and a 10-min equilibration at 1% B before
the next sample was injected. Precursor masses were
detected in the Orbitrap at R = 120,000 (m/z 200).
Fragment masses were detected in the linear ion trap at
unit mass resolution. Data-dependent MS/MS was
carried out with top of speed setting, cycle time 3 s with
dynamic exclusion of 30 s.
Protein identification and relative quantification were
carried out using the Proteome Discoverer software
package (Thermo Scientific). Raw data was searched
against a Mus musculus proteome database from Uni-
prot (2016-05-10) along with a contaminant protein
database with both Sequest HT and Mascot search en-
gines. Proteins annotated in Uniprot and/or reported in
the literature as functionally important in the skeletal
muscle [29] were extracted from the Uniprot database
and used to generate a subset skeletal muscle database
to assist further analysis. Cysteine carbomidomethylation
was set as a fixed modification. Methionine oxidation,
asparagine, and glutamine deamidation were set as vari-
able modifications. Peptide mass tolerance was ± 20 ppm
for search and later filtered to 5 ppm in consensus re-
port; fragment mass tolerance was ± 0.8 Da. Only pro-
teins with at least two peptides identified were
considered for further analysis. For relative quantifica-
tion, label-free quantification (LFQ) was carried out
using the MINORA feature detection followed by
precursor intensity quantification of unique and razor
peptides. Peptides with variable modifications were ex-
cluded from quantification. A protein was not quantified
if only detected in one replicate. Normalization between
samples was carried out based on total peptide amount.
Changes above twofold between WT and ASM−/− sam-
ples from the same muscle were considered significant
(ANOVA).
In vivo injury and measurement of isometric torque
In vivo testing of muscle force and susceptibility to in-
jury was performed as previously described [30–33].
Briefly, WT and ASM−/− mice 6–7 weeks old were anes-
thetized by inhalation anesthesia and placed in a supine
position. The animal’s thigh was stabilized and the ankle
secured to a lever arm. The axis of the knee was aligned
with the axis of a stepper motor, which was attached to
a torque sensor. The femoral nerve was stimulated with
subcutaneous needle electrodes to activate the quadri-
ceps muscle. Contractile activation, onset of forced knee
flexion, and torque data collection were synchronized
with the use of custom software. In this system, a repro-
ducible QF injury is produced through forced lengthen-
ing superimposed onto maximal isometric contractions,
through a 60 deg arc of motion at an angular velocity of
900°, beginning 200 ms after tetanic stimulation. Max-
imal isometric torque was measured before injury and at
selected time points after injury (0 and 2min). After in-
jury, the animals were removed from the apparatus and
returned to the cage for monitoring. For each genotype,
seven female mice were analyzed. Controls included
sham procedures (contractions without lengthening or
passive lengthening without contractions, both with the
thigh immobilized) [34].
Results
ASM−/− muscle fibers show altered intracellular Ca2+
handling in an excitation-contraction coupling assay
Flexor digitorum brevis (FDB) muscle fibers can be effi-
ciently isolated from mice by dissection and collagenase
digestion and, for this reason, have been extensively used
to study fundamental aspects of muscle function at the
single fiber level. To obtain an initial assessment of the
functional impact of ASM deficiency on isolated FDB
fibers, we utilized a Ca2+ mobilization assay, previously
used to characterize excitation-coupling (E-C) defects in
various mouse models of muscle disease [26]. Fura-2
was used to detect changes in intracellular Ca2+ in
response to electrical stimulation of FDB muscle fibers
at physiologically relevant stimulation frequencies (i.e.,
10–150 Hz). There was a significant reduction in peak
Fura-2 ratio at the higher stimulation frequencies in
ASM−/− fibers compared to WT fibers (Fig. 1a). Specific-
ally, the peak Fura-2 ratios of ASM−/− fibers were
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significantly lower compared to WT fibers at 50 Hz
(0.959 ± 0.053 vs. 0.775 ± 0.041), 70 Hz (0.853 ± 0.050 vs.
1.046 ± 0.065), 100 Hz (0.924 ± 0.063 vs.1.180 ± 0.080),
120 Hz (0.948 ± 0.062 vs. 1.237 ± 0.077), and 150 Hz
(0.988 ± 0.067 vs. 1.233 ± 0.085). These data indicated
that peak intracellular Ca2+ in response to muscle
depolarization was impaired and suggested alterations in
excitation-contraction coupling and/or impaired Ca2+
mobilization. The observed differences at the highest
stimulation frequencies further suggested a deficit in
stored intracellular Ca2+.
After monitoring the response of FDB fibers to single
stimulations across a range of frequencies, the Fura-2
response to repeated tetanic contractions at a high
frequency (100 Hz) was assessed in order to determine
(i) the ability to sustain repeated contractions and (ii)
the ability to recover from a bout of repeated tetanic
contractions. The latter was previously shown to be im-
paired in other muscle disorders [35], as it challenges
the ability of muscle fibers to sustain cyclical periods of
Ca2+ release and uptake. Repeated tetanic stimulation
was applied until the peak Fura-2 ratio was reduced to
50% of its initial value [27]. This 50% reduction in peak
Ca2+ transient level was previously shown to correspond
to a 70% decrease in force in isolated fibers subjected to
repeated contractions and was defined as the point of
fatigue [28]. Recovery was assessed 30 and 60min after
the fibers reached this fatigue point. In response to
repeated tetanic contractions, peak Fura-2 was reduced
to 50% of the initial levels in WT fibers by 4.64 ± 0.27min.
In ASM−/− FDB fibers, the average time to reach 50% of
peak Fura-2 was 3.53 ± 0.26min, which was significantly
Fig. 1 ASM−/− FDB fibers show defects in excitation-contraction coupling and recovery from repeated tetanic contractions. FDB fibers were
isolated from six ASM-deficient mice (ASM−/−) and six wild type littermates (WT) and subjected to electrical field stimulation to activate Ca2+
release and muscle fiber contraction. a Peak Fura-2 ratios of single FDB fibers at baseline in response to stimulation across a range of
physiological activation frequencies. ASM−/− fibers showed significantly lower peak Fura-2 ratios than WT fibers at baseline. *p = 0.020 at 70 Hz,
p = 0.001 at 100 Hz, p = 0.001 at 120 Hz, p = 0.008 at 150 Hz. b Average time to 50% of initial peak Fura-2 ratio during repeated 100 Hz tetanic
contractions. Significantly lower values were observed in ASM−/− fibers when compared to WT. *p = 0.011. c Peak Fura-2 ratios of single FDB fibers
during measurements after 60 min of recovery from repeated tetanic contractions. No significant differences were observed at 60 min recovery in
peak Fura-2 ratios between ASM−/− and WT fibers. d Number of fibers responding to electrical stimuli at baseline and at 30 or 60 min of recovery
from repeated tetanic contractions. No significant differences were observed in the total number of responsive fibers between WT or ASM−/−
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different from WT fibers (Fig. 1b). Thus, ASM−/− FDB
fibers were not able to sustain intracellular peak Ca2+
levels in response to repeated 100Hz tetanic contractions
and thus appeared to reach a point of fatigue faster than
WT FDB fibers.
In WT fibers, there were no significant differences
between peak Fura-2 ratios at baseline and after 60 min
of recovery from repeated tetanic contractions. Interest-
ingly, ASM−/− fibers showed significantly higher peak
Fura-2 levels after 60 min of recovery from repeated
contractions. Specifically, the Fura-2 ratios of ASM−/−
fibers were significantly higher at 60 min after repeated
tetanic contractions when compared to baseline at 70 Hz
(1.021 ± 0.085 vs. 0.853 ± 0.050) and 120 Hz (1.182 ±
0.133 vs. 0.948 ± 0.062), and trended towards signifi-
cance at rest (0.317 ± 0.040 vs. 0.269 ± 0.009; p = 0.065),
10 Hz (0.553 ± 0.047 vs. 0.492 ± 0.054; p = 0.055), 50 Hz
(0.885 ± 0.061 vs. 0.775 ± 0.041; p = 0.076), and 100 Hz
(1.108 ± 0.119 vs. 0.924 ± 0.063; p = 0.079) (compare
Fig. 1a with Fig. 1c). Thus, despite the reductions in
peak Fura-2 ratio in ASM−/− compared to WT fibers
observed at baseline (Fig. 1a), we found no significant
differences in peak Fura-2 ratio after 60 min of recovery.
Furthermore, from a total of 17 WT fibers that
responded with an elevation of [Ca2+]i at baseline, 11
(64%) also responded to all stimulation frequencies after
30 min of recovery from repeated tetanic contractions,
and this number decreased to 8 (47%) after 60 min of re-
covery. From 16 ASM−/− fibers, 12 (75%) responded
after a 30-min recovery, and this number decreased
to 5 (31%) after a 60-min recovery from repeated tet-
anic contractions (Fig. 1d). Thus, a similar number of
fibers from both groups responded at 30-min (results
not shown) and 60-min post-RTC (Fig. 1d) after repeated
tetanic contractions.
These data indicate that FDB fibers from ASM−/− mice
are impaired in E-C coupling when compared to WT,
resulting in reduced Ca2+ release from the sarcoplasmic
reticulum (SR). ASM−/− fibers reach a failure point for
maintaining [Ca2+]i (and thus would fatigue) sooner dur-
ing repeated bouts of activation and, surprisingly, also
show an enhanced peak tetanic Ca2+ transient following
repetitive activation. These data suggest alterations in
intracellular Ca2+ handling and storage in the absence of
ASM expression.
WT and ASM−/− muscle fibers express similar levels of
most proteins that regulate muscle function
The reduced peak [Ca2+]i in response to stimulation of
ASM−/− FDB fibers when compared to WT fibers
(Fig. 1a) raised the possibility that ASM−/− and WT FDB
fibers might express different levels of proteins involved
in regulating cytosolic Ca2+ levels. To address this
possibility, we performed state-of-the-art quantitative
proteomic analyses of three skeletal muscles in WT and
ASM−/− mice: FDB, quadriceps femoris QF, and TP. Pro-
tein profiling by nanoscale liquid chromatography
coupled to tandem mass spectrometry (nano LC-MS/
MS) and Uniprot database search identified 982 protein
groups (herein referred to as master proteins) in QF,
1017 in FDB, and 944 in TP from WT animals and 972
master proteins in QF, 1037 in FDB, and 948 in TP from
ASM−/− animals, with an extensive overlap between the
three different muscles (Fig. 2). Label-free quantification
(LFQ) showed that protein abundance in the three mus-
cles was consistent among all three biological replicates
for both WT and ASM−/− (Fig. 3a, Additional file 1: Fig-
ure S1A), with > 80% overlap between the three muscles
analyzed. By comparing the relative abundance of all
protein groups detected in each muscle for both geno-
types, we found that significant changes of more than
twofold in master proteins were 6.1% (downregulated)
and 4.7% (upregulated) in QF, 8% (downregulated) and
3% (upregulated) in FDB, and 5.3% (downregulated) and
4.2% (upregulated) in TP ASM−/− mice, when compared
to WT (Fig. 3b, Additional file 1: Figure S1B, Add-
itional file 2: Table S1, Additional file 3: Table S2, Add-
itional file 4: Table S3). We also compared WT and
ASM−/− samples for the relative abundance of proteins
in a subset database assembled using the skeletal muscle
annotation in Uniprot (https://www.uniprot.org/), sup-
plemented with functionally important skeletal muscle
proteins curated from the literature [29] (Fig. 2, Add-
itional file 5: Table S4). Of the 227 master proteins in
this mouse skeletal muscle protein subset database, 207
were detected in QF, 217-220 in FDB, and 196-199 in
TP, with extensive overlap (~ 80%) among the three
muscles, for both mouse genotypes (Fig. 2, Add-
itional file 5: Table S4). Thus, despite the variations in
fiber type composition among mouse FDB, QF, and TP
[36], the overall muscle protein abundance was similar
among the muscle types analyzed. No statistically signifi-
cant differences were observed in more than 94% of the
total master proteins in the skeletal muscle database,
when we compared WT and ASM−/− QF, FDB, and TP
samples (Fig. 3c, Additional file 1: Figure S1C, Add-
itional file 5: Table S4, Additional file 6: Table S5). This
common core of similarly expressed and functionally im-
portant skeletal muscle proteins includes several pro-
teins involved in Ca2+ handling, E-C coupling, and
sarcolemma integrity, such as the voltage-sensing dihy-
dropyridine receptor (DHPR), the ryanodine receptor
(RYR), the SR Ca2+ ATPase (SERCA), dystrophin, des-
min, tropomyosin, troponin C, and calpains. Interest-
ingly, among the few proteins from the skeletal muscle
subset that were significantly altered in expression level
between WT and ASM−/− muscles was calsequestrin,
which was downregulated in all three muscles from
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ASM−/− mice (Fig. 3c, Additional file 1: Figure S1C), a
finding confirmed by Western blot analysis (Add-
itional file 1: Figure S1C). Given calsequestrin’s role as a
large capacity Ca2+-binding protein inside the SR terminal
cisterna [37], its reduced expression level may be related,
at least in part, to the defect we observed in the
EC-coupling Ca2+ mobilization assays with ASM−/− FDB
fibers (Fig. 1). Dystrobrevin-α was significantly upregu-
lated in ASM−/− FDB and QF samples, but not in TP
(Fig. 3c, Additional file 1: Figure S1C). The relevance of
this finding is not clear, considering that other compo-
nents of the dystrophin-associated complex such as dys-
trophin, dystroglycan, sarcoglycan, and syntrophins were
not significantly altered (Additional file 5: Table S4, Add-
itional file 6: Table S5). In FDB samples, but not in QF or
TP, the proteomic analyses revealed a borderline signifi-
cant upregulation of the SR Ca2+ ATPase SERCA1 in
ASM−/− samples (Fig. 3c). Given the importance of SERCA1
for transferring Ca2+ from the cytosol to the lumen of the
SR in skeletal muscle [38] and the Ca2+ mobilization defect
we observed in FDB fibers, we followed up on this observa-
tion by examining SERCA1 expression levels in four bio-
logical replicates of WTand ASM−/− FDB fibers by Western
blot with specific antibodies to SERCA1. Although a slight
apparent increase in SERCA1 content (relative to the tubu-
lin amount in the same samples) was observed in ASM−/−
FDB, the difference was not statistically significant (Fig. 2d).
Taken together, our proteomic analyses indicate that dele-
tion of the gene encoding ASM (SMPD1) alters the expres-
sion of only a small number of proteins known to be
associated with skeletal muscle function. Among these, the
downregulation of calsequestrin in ASM−/− samples may be
functionally important, since it occurred in the three dif-
ferent muscles analyzed.
Fig. 2 Venn diagrams of the overlap between master proteins detected in TP, FDB, and QF muscle fibers. Top diagrams, overlap between the
three muscles of all master proteins detected for WT or ASM−/−; bottom diagrams, overlap between the three muscles of proteins from a skeletal
muscle subset database assembled using the skeletal muscle annotation in Uniprot (https://www.uniprot.org/), supplemented with functionally
important skeletal muscle proteins curated from the literature [29]
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Fig. 3 Comparative proteomic analysis of QF and FDB muscle fibers from WT and ASM−/− mice. a Protein abundance values for three biological
replicates of WT or ASM−/− QF and FDB muscles isolated from WT and ASM−/− mice. b Volcano plots indicating statistically significant (P < 0.05)
differences between WT and ASM−/− samples in the expression of all master proteins identified for QF and FDB muscles. Green box, proteins
downregulated more than twofold in ASM−/− relative to WT; pink box, proteins upregulated more than twofold in ASM−/− relative to WT.
c Volcano plots indicating statistically significant (P < 0.05) differences between WT and ASM−/− samples in the expression of master proteins
within a subset of functionally important skeletal muscle proteins, in QF and FDB muscles. Green box, proteins downregulated more than twofold
in ASM−/− relative to WT; pink box, proteins upregulated more than twofold in ASM−/− relative to WT. d FDB fibers isolated from four WT mice
and four ASM−/− mice were solubilized and analyzed by Western blot with anti-SERCA1 antibodies (each lane corresponds to fibers isolated from
one animal). Antibodies against α-tubulin were used as a loading control. e Densitometry values of the data in d expressed as SERCA1/α-tubulin
ratio, showing no significant differences between the amount of SERCA1 in WT and ASM−/− FDB fibers.
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Repair of the sarcolemma after injury is impaired in
ASM−/− muscle fibers
Previous studies showed that muscle fibers rapidly reseal
wounds in their sarcolemma in a Ca2+-dependent man-
ner [25, 39]. However, so far, most studies of the muscle
repair process have involved non-physiological forms of
wounding such as burning holes on the sarcolemma of
individual fibers with lasers, an approach that only
allows analysis of small numbers of individual fibers in
each assay [40]. To overcome these problems, we devel-
oped a population assay where the resealing capacity of
hundreds of skeletal muscle fibers could be assessed
simultaneously after mechanical injury. We injured iso-
lated mouse FDB muscle fibers in one rapid step, by pas-
sage through a 30-gauge needle. In the absence of Ca2+,
a condition that prevents PM repair [41], passage of
muscle fibers through the needle followed by exposure
to the membrane impermeant dye propidium iodide (PI)
revealed sarcolemma injury in the majority of fibers, de-
tected as PI-stained nuclei. On the other hand, wounded
fibers from wild type mice (WT) were able to reseal in
the presence of Ca2+, as indicated by the significant
reduction of PI staining compared to the Ca2+ free
condition (Fig. 4a, b).
Quantification by image analysis of large numbers of
individual fibers (> 200 for each condition) showed that
the amount of intracellular PI (fluorescence intensity) in
WT and ASM−/− fibers after injury in the absence of Ca2+
was similar, indicating that ASM−/− fibers were no more
susceptible than WT to mechanical injury (Fig. 4c). In
contrast, when the assay was performed in the presence
of Ca2+ (a condition required for sarcolemma repair), the
intracellular PI fluorescence intensity in WT fibers,
reflecting sarcolemma permeability, showed baseline levels
similar to those seen in fibers not subjected to the wound-
ing procedure. Fibers from ASM−/− mice, in contrast, did
not show a significant difference in PI staining in the
presence of Ca2+, a finding that is consistent with a defect
in sarcolemma repair after injury (Fig. 4c).
Earlier studies identified a role for sphingomyelinase-
mediated caveolar endocytosis in the repair of sarcolemma
injury in mouse FDB fibers [25]. To examine if ASM
Fig. 4 FDB fibers from ASM−/− mice are defective in Ca2+-dependent repair of the sarcolemma after mechanical injury. FDB fibers isolated from
ASM-deficient mice (ASM−/−) and their wild type littermates (WT) were left intact or injured by one passage through a 30-gauge needle. After
5 min at 37 °C, the fibers were exposed to PI, which only enters muscle fibers that sustained a sarcolemmal damage. a Brightfield and fluorescent
images of PI-stained fibers with or without needle wounding, in the presence (membrane repair permissive condition) or absence of
Ca2+ (membrane repair non-permissive condition). b Enlarged image showing PI staining of peripheral nuclei in wounded fibers. c Quantification of
PI fluorescence associated with un-contracted fibers (mean ± SE of ~ 200 fibers/animal/condition, for each experiment). The data are representative of
three independent experiments. WT fibers showed the expected Ca2+-dependent sarcolemma repair (**p= 0.040, WT +Ca2+ vs. no Ca2+), but no significant
resealing was observed in ASM−/− fibers (p= 0.668 ASM−/−+Ca2+ vs. no Ca2+)
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deficiency was associated with impaired sarcolemma
repair and reduced caveolar endocytosis, we examined
by TEM WT and ASM−/− fibers subjected or not to
the needle passage wounding protocol, followed by a
brief repair period. The overall morphology of unin-
jured WT and ASM−/− fibers was similar, with no ob-
vious abnormalities. In contrast, wounded ASM−/−
fibers were visibly altered, with markedly irregular
borders and an increase in intra-fiber low electron-density
material (Fig. 5a). Single rows of the typical < 100 nm
PM invaginations known as caveolae were present
along the sarcolemma of uninjured WT and ASM−/−
fibers (Fig. 5b, arrowheads). As previously described
[25], after injury and repair, the sub-sarcolemmal re-
gion of WT fibers contained a large number of inter-
nalized caveolar vesicles (Fig. 5b, arrows), consistent
with their previously proposed role in membrane re-
pair. Strikingly, however, this extensive intracellular
accumulation of caveolar vesicles was absent in
ASM−/− fibers (Fig. 5b). Thus, ASM deficiency is as-
sociated with impaired caveolar endocytosis and de-
fective sarcolemma repair.
ASM deficiency impairs the ability of skeletal muscle to
recover from injury in vivo
Recovery from some types of acute muscle injury can
occur without significant levels of myogenic cell prolifer-
ation [16], suggesting a role for rapid sarcolemma repair
(which is known to occur in less than 1 min [13, 15]).
Based on the defective sarcolemmal repair observed after
needle-injury, and the impaired ability to withstand
repeated tetanic contractions observed in isolated FDB
fibers from ASM−/− mice (Figs. 1 and 3), we hypothe-
sized that ASM deficiency might also interfere with the
ability of skeletal muscle to recover from an acute large
strain injury in vivo.
We tested this hypothesis using an in vivo animal
model developed for testing the contractile force of QF
muscle (Fig. 6a). This model results in the production of
a reliable muscle injury and allows assessment of muscle
functional recovery (maximal isometric torque) within
the same animal over time [30]. Using this model, we
found no significant differences in the maximal isomet-
ric torque (with and without normalization for body
weight) in the QF of WT and ASM−/− littermate mice
prior to injury (Fig. 6b, c). The body weights were not
significantly different between WT and ASM−/− mice,
suggesting no overall muscle atrophy or hypertrophy
(Fig. 6b). There was also no significant difference in the
amount of injury induced by forced lengthening contrac-
tions, as indicated by the maximal isometric torque mea-
sured immediately after (0 min) the large strain eccentric
injury (Fig. 6c). However, after 2 min (a time period
chosen for consistency with the fast sarcolemma
resealing process, and also to avoid secondary effects of
inflammation), a significant difference was observed:
while the loss in maximal isometric torque of WT mice
(28%) was unchanged compared to 0 min, in ASM−/−
mice, the loss was increased to 68% (Fig. 6d). These re-
sults suggest that QF muscles of ASM−/− mice are im-
paired in recovery from a large strain injury, possibly as
a consequence of defective sarcolemma repair, as ob-
served in FDB fibers (Figs. 4 and 5).
Discussion
In this study, we examined several aspects of skeletal
muscle function in ASM-deficient mice. Over time, these
animals develop a phenotype that closely mimics the
human diseases NPDA/B, including severe neurodegen-
eration and a shortened life span [23]. We limited our
studies to the first 8 weeks of life of the animals, prior to
the onset of neurological symptoms. First, we found that
isolated FDB fibers from ASM−/− mice exhibit lower
levels of peak intracellular Ca2+ after excitation in an
E-C coupling assay and have a more rapid decline in
peak tetanic Ca2+ in response to repeated tetanic con-
tractions. Second, using a quantitative proteomic ap-
proach, we detected the downregulation of the SR Ca2
+-buffering protein calsequestrin in the three different
skeletal muscles (FDB, QF, and TP) from ASM-deficient
animals, while > 90% of proteins associated with skeletal
muscle function were similarly expressed in ASM−/− and
WT mice. Third, using an in vitro assay for assessing
mechanical wounding and sarcolemma repair in isolated
FDB fibers, we found that ASM deficiency impairs the
ability of FDB fibers to reseal their sarcolemma after
injury. Finally, in vivo measurements of QF absolute
strength before and immediately after a lengthening
contraction-induced injury revealed no significant differ-
ences between WT and ASM−/− animals, suggesting
similar susceptibility to injury. However, a significantly
larger loss of maximal isometric torque was observed in
the QF of ASM−/− mice when the animals were tested
2-min post-injury, a period that is known to be sufficient
for full repair of PM wounds [8]. Thus, our study
provides direct evidence that ASM deficiency impairs
skeletal muscle function, possibly as a consequence of
defective sarcolemma repair after injury.
The degree of impairment from contraction-induced
injury depends not only on the muscle, but also on the
timing of muscle activation to lengthening, the amount
of muscle strain, and the velocity of movement [42].
Muscle lengthening (“eccentric”) contractions can result
in a significant and long-lasting deficit of force produc-
tion, but this requires a maximal contraction before and
during lengthening, as well as a high number of repeti-
tions. Such protocols show moderate susceptibility to
injury in healthy WT mice, but severe susceptibility to
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damage in animals with muscle diseases, such as mdx mice,
the murine model for Duchenne muscular dystrophy. Here,
we used a model of only 10 repetitions, which induces a
mild loss in muscle maximal force. An initial recovery that
occurs after 10 repetitions has been described before [43]
and precedes the further drop in force that is seen days
later [16, 44]. Long-term follow-up after injury was not the
focus of our study, as this involves mechanisms beyond
immediate sarcolemma resealing, such as cytoskeletal
restructuring and a peak of inflammation followed by
eventual resolution [45].
ASM deficiency was reported to cause overaccumulation
of sphingomyelin in the PM and lysosomes of ASM−/−
mouse fibroblasts, a process proposed to contribute to
membrane instability [46]. An overabundance of PM
sphingomyelin was also reported in spermatozoa of ASM−/−
mice, of which only 13.4% showed intact membranes in a
permeability assay [47]. However, only a very limited
number of studies have evaluated a potential impact
of ASM deficiency on skeletal muscle function. McGovern
et al. [48] found impaired pulmonary gas exchange in
NPDB patients using maximal exercise tolerance testing,
Fig. 5 ASM deficiency impairs the rapid intracellular accumulation of caveolar vesicles after injury, resulting in abnormal fiber morphology.
FDB fibers isolated from ASM-deficient mice (ASM−/−) and their wild type littermates (WT) were left intact or injured by one passage through
a 30-gauge needle. After 1 min at 37 °C, the fibers were fixed and processed for TEM. a Lower magnification TEM images of the overall
ultrastructural morphology of WT or ASM−/− fibers with or without wounding. Bars, 1 μm. b TEM images of three independent fibers per
condition at higher magnification. The arrowheads point to caveolae on the sarcolemma, and the arrows point to intracellular caveolar vesicles.
Bars, 200 nm. The images in a and b are representative of multiple images acquired from a total of approximately 40 individual fibers
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and Macauley et al. [49] found that the performance of
ASM−/− mice on Rotarod tests deteriorated after 7 weeks
of age. In view of our current findings, it is conceivable
that these previously observed functional defects are re-
lated to impaired muscle function.
Previous studies identified ASM as a critical compo-
nent of the mechanism of PM repair after injury. ASM is
secreted from lysosomes of cultured cells in response to
PM injury in the presence of Ca2+, and inhibition or
RNAi depletion of ASM strongly impairs the ability of
cells to repair wounds in their PM, in a process medi-
ated by endocytosis [8]. Similar results were obtained
with ASM-deficient fibroblasts derived from NPDA
patients, and extracellular addition of purified ASM
fully rescued the PM repair defect of these cells [8].
Subsequent studies showed that myotubes and iso-
lated mouse FDB muscle fibers show enhanced in-
ternalization of caveolar vesicles after wounding or
after extracellular exposure to ASM, raising the possi-
bility that ASM may regulate the repair of sarco-
lemma wounds by promoting lesion removal by
endocytosis [25]. In the present study, we obtained
further evidence in support of this hypothesis, by
demonstrating that isolated FDB fibers have a signifi-
cantly reduced ability to repair their sarcolemma after
mechanical injury.
Fig. 6 ASM deficiency impairs the ability of skeletal muscle to recover from injury in vivo. a Apparatus for muscle injury and isometric torque
measurements. The thigh of an anesthetized mouse is stabilized and the leg attached to a motor-driven arm. To assess quadriceps maximal
isometric torque, the femoral nerve is stimulated with transcutaneous electrodes, resulting in knee extension (see blue arrow). To induce injury,
the lever arm is forced down into flexion while the quadriceps muscle is fully contracted. Image modified from [32], used with permission.
b Average body weight of WT and ASM−/− littermate mice. No significant differences in body mass were observed between WT and ASM−/− mice.
c QF absolute strength, as measured by maximal isometric torque before injury. No significant differences were observed between WT and ASM−/−
littermate mice. d Percent loss of maximal isometric torque in QF muscle immediately after (0min) or 2min after a high-force lengthening contraction
injury in WT or ASM−/− littermate mice. ASM−/− mice showed a significantly higher loss of maximal isometric torque at 2-min post-injury when
compared to WT (*p = 0.0023). All data represent the mean ± SD of seven mice in each group
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ASM-deficient FDB fibers exhibited a significant reduc-
tion in the average time to reach 50% of the initial peak
Fura-2 ratio during repeated tetanic contractions, a par-
ameter that was previously associated with muscle fatigue
[28]. This finding may reflect a reduced ability of the fibers
to repair sarcolemma wounds inflicted during repeated
contraction-relaxation cycles. We also observed lower
peak [Ca2+]i in ASM
−/− FDB during baseline measure-
ments in the presence of Ca2+. This suggests a defect prior
to or during Ca2+ release from the SR in response to elec-
trical stimulation. Propagation of the action potential
across the sarcolemma and the T-tubules is important for
activating SR-Ca2+ release, through critical interactions
between the voltage-sensing receptor DHPR and the SR
Ca2+ release channel RYR. Membrane depolarization de-
fects are expected to disrupt voltage-sensing by the
DHPR, reducing SR-Ca2+ release [50]. Thus, changes in
T-tubule and/or SR membrane composition as a conse-
quence of ASM deficiency may also be considered as a po-
tential explanation for our observations. However, the
lower peak [Ca2+]i of ASM
−/− FDB during baseline mea-
surements in E-C assays may also be related to a defect in
sarcolemma repair, since ASM−/− fibers with unrepaired
wounds may have a reduced capacity to propagate an ac-
tion potential, leading to diminished SR-Ca2+ release. Fi-
nally, the reduction in calsequestrin detected in our
proteomic analyses is likely responsible for the reductions
in [Ca2+]i at the high stimulation frequencies and may also
be responsible for the altered response to repeated tetanic
contractions. Previous studies in calsequestrin knockout
mice showed that peak intracellular Ca2+ levels are
reduced during sustained tetanic contractions, due to
depletion of SR Ca2+ stores [51].
Conclusions
We report a novel phenotype in a mouse model of NPDA/B
that lacks the lysosomal enzyme ASM. Skeletal muscle from
ASM−/− mice have an impairment in intracellular Ca2+
handling that results in reduced Ca2+ mobilization and a
more rapid decline in peak Ca2+ transients during repeated
contraction-relaxation cycles. Isolated skeletal muscle fibers
show an impaired ability to repair sarcolemma damage, and
this was associated with an exaggerated deficit in force dur-
ing recovery from an in vivo muscle injury. Our findings in
this animal model suggest that specific skeletal muscle phe-
notypes may have been previously overlooked in NPDA/B
patients and deserve further investigation.
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